Impact of Exercise on Muscle Metabolism and Function for Persons With Parkinsons
Part of paid clinical trials in Dallas, Texas.
- Sponsor
- University of Texas Southwestern Medical Center
- Study ID
- NCT07720713
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 50 Years - 80 Years
- Healthy Volunteers
- Accepted
Interventions
- Home Exercise Program — OTHERAll participants completed a four-week, home-based progressive strengthening program targeting GM using high-volume bodyweight exercise. Participants were instructed to perform exercises three times per week, with at least one day of rest between exercise sessions. During weeks 1 and 2, participants performed two sets of heel raises to fatigue at their prescribed level, corresponding to a subjective effort rating of 8/10. The goal was to progress toward completing 20 repetitions per set. Exercise loading was individualized based on baseline performance and adjusted throughout the intervention according to each participant's demonstrated strength progression.
Study Details
This investigation assesses the impact of a strengthening program on muscle metabolism in the gastrocnemius muscle (GM) and is an essential step in the establishment of future clinical intervention for the GM in people with Parkinson's disease (with healthy peers as the control group). The participants will be provided with a progressive GM strengthening program while monitoring muscle metabolism and functional changes before and after intervention.
Key Dates
- First listed
- Jul 22, 2026
- Start date
- Apr 27, 2022
- Status verified
- Jul 2026
- Primary completion
- Jun 30, 2023
- Completion
- Jun 30, 2023
Study Design
- Enrollment
- 19 participants (actual)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Home exercise programHome exercise program for gastrocnemius strengthening
Primary Outcome Measure
Muscle metabolic properties (P-31 MRS) [ Time Frame: Day 1 (baseline) and 4 weeks (post exercise program) ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| UT Southwestern Medical Center | Dallas | Texas | 75235 | - |
Find similar trials in Dallas, TX
By condition
By specialty
By research site
Related Studies
- A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's DiseasePHASE2 · Recruiting · Neuron23 Inc. · Sun City, Arizona
- Neurologic Stem Cell Treatment StudyRecruiting · MD Stem Cells · Westport, Connecticut
- Study of Gastrointestinal Dysfunction and Enteric Neural Pathology in Patients With Parkinson's DiseaseEnrolling By Invitation · Massachusetts General Hospital · Boston, Massachusetts
- Colonoscopic Detection of Phosphorylated Alpha-synuclein for Parkinson's DiagnosisRecruiting · CND Life Sciences · Portland, Oregon